For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...

CKD and ESRD can have unpleasant cutaneous manifestations, including alopecia, but there are several helpful approaches to mitigating hair loss.

A research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

The researchers tested their new itaconate-based prodrugs in mice and found that at least two of them were highly effective. The treatment was well-absorbed, reduced inflammation, and stimulated hair ...

Bempikibart demonstrated positive, durable responses among patients with severe to very severe alopecia areata, according to ...

Masumi Tsunoda, a 45-year-old woman in Maebashi, Gunma Prefecture, who is an alopecia areata patient, was asked to design a headscarf for Licca-chan. Tsunoda contracted the disease 10 years ago.

The rising prevalence of prediabetes among young adults signals early metabolic dysfunction, significantly increasing the ...

Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...